SCHEMBL5378798

SCHEMBL5378798

CCc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.58
ACLY P53396 2/20 0.55
KIF11 P52732 2/20 0.52
MEN1 O00255 1/20 0.51
ALOX15 P16050 1/20 0.51
MAPK1 P28482 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
PSEN1 P49768 1/20 0.49
PSEN2 P49810 1/20 0.49
APH1B Q8WW43 1/20 0.49
NCSTN Q92542 1/20 0.49
APH1A Q96BI3 1/20 0.49
PSENEN Q9NZ42 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382304 0.89 MEN1 (0.55) KDM1AACLYKIF11MEN1ALOX15
SCHEMBL5373250 0.86 POLB (0.63) KDM1AACLYKIF11MEN1ALOX15
SCHEMBL5376936 0.86 POLB (0.52) KIF11HDAC3HDAC4HDAC1HDAC7
SCHEMBL5371913 0.86 ALDH1A1 (0.47) KDM1AMEN1ALOX15MAPK1KMT2A
SCHEMBL5368406 0.84 PTPN1 (0.71) MEN1KMT2AMAPTPTPN5HSPD1
SCHEMBL5368419 0.81 POLB (0.66) KDM1AACLYMEN1ALOX15MAPK1
SCHEMBL5368443 0.80 SMN1; SMN2 (0.53) MEN1MAPK1KMT2AMAPTUCHL1
SCHEMBL5380381 0.80 POLB (0.61) KDM1AACLYMEN1ALOX15MAPK1
SCHEMBL5378681 0.79 MAPT (0.50) MEN1KMT2ACYP3A4HDAC3HDAC1
SCHEMBL5371871 0.77 MEN1 (0.57) KDM1AKIF11MEN1ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDM1A 4634/4885ACLY 563/4885KIF11 3574/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD KDM1A 4581/4885ACLY 360/4885KIF11 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.